BIO Medical Applications Of Alabama Inc in Decatur, Alabama - Dialysis Center

BIO Medical Applications Of Alabama Inc is a medicare approved dialysis facility center in Decatur, Alabama and it has 20 dialysis stations. It is located in Morgan county at 2834 Spring Avenue Sw, Decatur, AL, 35603. You can reach out to the office of BIO Medical Applications Of Alabama Inc at (256) 885-1740. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Alabama Inc has the following ownership type - Profit. It was first certified by medicare in February, 2017. The medicare id for this facility is 012692 and it accepts patients under medicare ESRD program.

Name	BIO Medical Applications Of Alabama Inc
Location	2834 Spring Avenue Sw, Decatur, Alabama
No. of Dialysis Stations	20
Medicare ID	012692
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with BIO Medical Applications Of Alabama Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1760839922
Organization Name	Fresenius Medical Care Decatur
Doing Business As	Bio-medical Applications Of Alabama, Inc.
Address	2834 Spring Ave Sw Decatur, Alabama, 35603
Phone Number	(256) 306-4735

Dialysis patients with Hemoglobin data	11
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	27

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	28
  Adult patient months included in Kt/V greater than or equal to 1.2	128
  Percentage of adult patients getting regular hemodialysis at the center	98
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BIO Medical Applications Of Alabama Inc with elevated calcium levels.

Patients with hypercalcemia	28
Hypercalcemia patient months	128
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	30
Patients with Serumphosphor less than 3.5 mg/dL	1
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	19
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	26
Patients with Serumphosphor from 5.6 to 7 mg/dL	37
Patients with Serumphosphor greater than 7 mg/dL	16

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	30
Patient months included in arterial venous fistula and catheter summaries	137
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	77
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	9